scholarly article | Q13442814 |
P50 | author | John S Klassen | Q87677701 |
Ming Tan | Q90231711 | ||
P2093 | author name string | Ling Han | |
Ming Xia | |||
Pengwei Huang | |||
Xi Jiang | |||
Wen Jiang | |||
Weiming Zhong | |||
Chen Sun | |||
Kunpeng Li | |||
Frank S Vago | |||
P2860 | cites work | The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors | Q24563224 |
Rotavirus and severe childhood diarrhea | Q24605360 | ||
Structural basis for the recognition of blood group trisaccharides by norovirus | Q24682901 | ||
X-ray crystallographic structure of the Norwalk virus capsid | Q27619935 | ||
Structural Basis for the Receptor Binding Specificity of Norwalk Virus | Q27650214 | ||
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus | Q27651029 | ||
Atomic model of an infectious rotavirus particle | Q27666313 | ||
Crystal Structures of GII.10 and GII.12 Norovirus Protruding Domains in Complex with Histo-Blood Group Antigens Reveal Details for a Potential Site of Vulnerability | Q27667594 | ||
Structural Analysis of Histo-Blood Group Antigen Binding Specificity in a Norovirus GII.4 Epidemic Variant: Implications for Epochal Evolution | Q27670610 | ||
Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group Antigens | Q27671411 | ||
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen | Q27678512 | ||
Unexpected fold in the circumsporozoite protein target of malaria vaccines | Q27678840 | ||
Structural Analysis of Determinants of Histo-Blood Group Antigen Binding Specificity in Genogroup I Noroviruses | Q27682308 | ||
Global burden of childhood pneumonia and diarrhoea | Q28288886 | ||
Glycan Specificity of P[19] Rotavirus and Comparison with Those of Related P Genotypes | Q28821791 | ||
Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy | Q30234848 | ||
Norovirus gastroenteritis, carbohydrate receptors, and animal models | Q33701801 | ||
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns | Q33788719 | ||
Subviral particle as vaccine and vaccine platform | Q33812653 | ||
Branched-linear and agglomerate protein polymers as vaccine platforms | Q34064413 | ||
Norwalk virus assembly and stability monitored by mass spectrometry. | Q34121907 | ||
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors | Q34123964 | ||
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis | Q34227701 | ||
Structural requirements for the assembly of Norwalk virus-like particles | Q34335587 | ||
Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production | Q34485266 | ||
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles | Q34724844 | ||
Systematic literature review of role of noroviruses in sporadic gastroenteritis | Q34804404 | ||
Norovirus-host interaction: multi-selections by human histo-blood group antigens | Q35146233 | ||
Structure determination of feline calicivirus virus-like particles in the context of a pseudo-octahedral arrangement | Q35201812 | ||
A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface | Q35683789 | ||
A Bayesian view on cryo-EM structure determination. | Q35859527 | ||
Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells | Q35896548 | ||
Rotavirus vaccines: update on global impact and future priorities | Q35918823 | ||
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner | Q35943850 | ||
Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus | Q36110059 | ||
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens | Q36246385 | ||
Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic | Q36255811 | ||
Noroviral P particle: structure, function and applications in virus-host interaction | Q36429481 | ||
Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus | Q36445296 | ||
A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus | Q36519453 | ||
Polyvalent complexes for vaccine development | Q36792270 | ||
Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus | Q36914794 | ||
A dual vaccine candidate against norovirus and hepatitis E virus | Q37502688 | ||
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design | Q37792984 | ||
Virus-like particle-based human vaccines: quality assessment based on structural and functional properties | Q38152530 | ||
Histo-blood group antigens: a common niche for norovirus and rotavirus | Q38194256 | ||
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial | Q38797322 | ||
Recent advancements in combination subunit vaccine development | Q38819439 | ||
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial | Q38879736 | ||
Detailed analysis of BALB/c mice challenged with wild type rotavirus EDIM provide an alternative for infection model of rotavirus | Q39118286 | ||
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial | Q39944921 | ||
Gctf: Real-time CTF determination and correction | Q41603517 | ||
Intussusception risk after rotavirus vaccination in U.S. infants | Q42232989 | ||
Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). | Q45274597 | ||
Risk of intussusception after monovalent rotavirus vaccination | Q46186510 | ||
Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry | Q46851930 | ||
Rotavirus vaccines--balancing intussusception risks and health benefits | Q47119066 | ||
Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants | Q57530944 | ||
P433 | issue | 11 | |
P921 | main subject | nanoparticle | Q61231 |
P304 | page(s) | 10665-10682 | |
P577 | publication date | 2018-09-25 | |
P1433 | published in | ACS Nano | Q2819067 |
P1476 | title | Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform | |
P478 | volume | 12 |
Q104289416 | Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine |
Q92759295 | Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice |
Q90231715 | Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development |
Search more.